BRUSSELS (Reuters) – The head of the European Medicines Agency (EMA) on Tuesday said that it could soon approve the COVID-19 vaccine developed by U.S. biotech company Novavax.
“The vaccine from Novavax could be authorised in the very near future,” Emma Cooke told EU health ministers during a public session of a meeting in Brussels.
(Reporting by Francesco Guarascio; Editing by David Goodman)
